NF-kappa-B essential modulator (NEMO) (NEMO)

NF-kappa-B essential modulator (NEMO), also known as IKK-gamma, is a critical regulatory scaffold protein that organizes the IκB kinase (IKK) complex, the central gatekeeper of the canonical NF-κB signaling pathway (UniProt P51948). It lacks catalytic activity but acts as a platform for the assembly and activation of the catalytic subunits IKKα and IKKβ in response to various stimuli such as pro-inflammatory cytokines and microbial products (PubMed 10485908). By binding to polyubiquitin chains and recruiting kinases, NEMO facilitates the phosphorylation and subsequent degradation of IκB proteins, allowing NF-κB transcription factors to translocate to the nucleus and activate genes involved in immunity, inflammation, and cell survival (NIH PMC3661113). Dysregulation of NEMO is linked to several human diseases, including incontinentia pigmenti and ectodermal dysplasia, while its overactivity is a hallmark of many cancers and chronic inflammatory conditions (StatPearls). Therapeutic strategies targeting NEMO often focus on disrupting its interaction with the catalytic IKK subunits using NEMO-binding domain (NBD) peptides or small-molecule mimetics to selectively inhibit the pathway (PubMed 21170055). However, systemic inhibition of this scaffold poses significant safety challenges, including potential liver toxicity and profound immunosuppression due to the pathway's essential role in normal physiology (PubMed 30104371).

Other names

IKK-gammaIKBKGFIP-3NF-kappa-B essential modifierInhibitor of nuclear factor kappa-B kinase subunit gammaIKKAP1AMCBX1

Disruption of the IKK complex assembly by inhibiting the protein-protein interaction between the regulatory scaffold NEMO and the catalytic subunits IKKα and IKKβ, thereby preventing IκBα phosphorylation and subsequent NF-κB nuclear translocation.